Impact of hemoglobin (Hb) on outcomes of adjuvant chemotherapy (ACT) with cisplatin/vinorelbine in patients (pts) with completely resected non-small cell lung cancer (NSCLC) in JBR.10.

被引：0
|
作者：
Gauthier, I
Ding, K
Winton, T
Shepherd, F
Livingston, R
Johnson, DH
Rigas, JR
Whitehead, M
Graham, B
Seymour, L
机构：
[1] Natl Canc Inst, Kingston, ON, Canada
[2] SW Oncol Grp, Seattle, WA USA
[3] Eastern Cooperat Oncol Grp, Nashville, TN USA
[4] Canc & Leukemia Grp B, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：670S / 670S
页数：1
相关论文
共 50 条
  • [1] Do hemoglobin (Hb) levels influence outcomes of adjuvant chemotherapy (ACT) with cisplatin/vinorelbine in patients (pts) with completely resected non small cell lung cancer (NSCLC)? The JBR.10 trial experience
    Gauthier, I
    Ding, K
    Winton, T
    Shepherd, F
    Livingston, R
    Johnson, D
    Rigas, J
    Whitehead, M
    Graham, B
    Seymour, L
    [J]. LUNG CANCER, 2005, 49 : S280 - S280
  • [2] Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: The JBR.10 trial experience
    Gauthier, I.
    Ding, K.
    Winton, T.
    Shepherd, F. A.
    Livingston, R.
    Johnson, D. H.
    Rigas, J. R.
    Whitehead, M.
    Graham, B.
    Seymour, L.
    [J]. LUNG CANCER, 2007, 55 (03) : 357 - 363
  • [3] A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10.
    Winton, TL
    Livingston, R
    Johnson, D
    Rigas, J
    Cormier, Y
    Butts, C
    Ding, K
    Seymour, L
    Magoski, N
    Shepherd, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 621S - 621S
  • [4] Split-dose Cisplatin and Vinorelbine as Adjuvant Chemotherapy for Completely Resected Non-small Cell Lung Cancer
    Hirai, Fumihiko
    Seto, Takashi
    Shimokawa, Mototsugu
    Inamasu, Eiko
    Toyozawa, Ryo
    Toyokawa, Gouji
    Yoshida, Tsukihisa
    Shiraishi, Yoshimasa
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    [J]. ANTICANCER RESEARCH, 2014, 34 (02) : 927 - 931
  • [5] Outcomes of patients undergoing adjuvant platinum-vinorelbine chemotherapy for resected non-small cell lung cancer (NSCLC)
    Pender, A.
    Coward, J.
    Gunapala, R.
    Bhosle, J.
    O'Brien, M.
    Popat, S.
    [J]. LUNG CANCER, 2013, 79 : S12 - S12
  • [6] Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation
    Douillard, Jean-Yves
    Tribodet, Helene
    Aubert, Delphine
    Shepherd, Frances A.
    Rosell, Rafael
    Ding, Keyue
    Veillard, Anne-Sophie
    Seymour, Lesley
    Le Chevalier, Thierry
    Spiro, Stephen
    Stephens, Richard
    Pignon, Jean Pierre
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 220 - 228
  • [7] Lung adjuvant cisplatin evaluation (Lace Vinorelbine Project): Pooled analysis of adjuvant vinorelbine-cisplatin trials for completely resected non-small cell lung cancer (NSCLC)
    Douillard, Jean-Yves
    Tribodet, Helene
    His, Patricia
    Shepherd, Frances
    Ding, Keyue
    Winton, Timothy
    Le Chevalier, Thierry
    Spiro, Stephen
    Stephens, Richard
    Pignon, Jean-Pierre
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 213 - 213
  • [8] Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
    Pirker, Robert
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (05) : 305 - 310
  • [9] Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
    Liang, Ying
    Wakelee, Heather A.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 403 - 410
  • [10] A FEASIBILITY STUDY OF SPLIT-DOSE CISPLATIN AND VINORELBINE AS ADJUVANT CHEMOTHERAPY FOR COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER
    Hirai, Fumihiko
    Toyozawa, Ryou
    Inamasu, Eiko
    Kojo, Miyako
    Toyokawa, Gouji
    Shiraishi, Yoshimasa
    Morodomi, Yosuke
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S483 - S483
12345